Gastroenterology Devices
The U.S. gastroenterology device market is expanding with rising gastrointestinal disorders, increasing screening programs, and advances in minimally invasive technologies. Our research provides comprehensive analysis of market dynamics, product innovation, competitive positioning, and future industry outlook.
The U.S. outpatient gastroenterology devices market is expanding rapidly, projected to grow from USD 6.08 billion in 2026 to USD 9.82 billion by 2032 at an 8.32% CAGR. Growth is fueled by lower colorectal cancer screening ages, accelerated procedure migration from hospitals to ambulatory surgery centers, rising adoption of edge-AI endoscopy, and demand for single-use infection-prevention devices.
Read Report Details
The U.S. ambulatory gastroenterology devices market is expanding rapidly, projected to rise from USD 9.87 billion in 2026 to USD 16.14 billion by 2032 at an 8.54% CAGR. Growth is driven by the migration of colonoscopies to ambulatory surgery centers, lowering of colorectal screening ages, adoption of artificial intelligence detection, and transition toward single-use and infection-controlled endoscopic technologies across outpatient suites.
Read Report Details
The U.S. Digital Gastroenterology Devices Market is projected to grow from USD 6.75 billion in 2026 to USD 12.85 billion by 2032 at an 11.33% CAGR. Market expansion is fueled by lowering the colorectal screening age to 45, rapid procedural migration into ambulatory surgery centers, widespread clinical adoption of AI CADe/CADx lesion detection, and the growing transition toward single-use digital endoscopes.
Read Report Details
The U.S. disposable gastroenterology devices market is experiencing rapid expansion, projected to grow from USD 4.02 billion in 2026 to USD 7.84 billion by 2032 at an 11.78% CAGR. Driven by rigorous hospital infection-control mandates, rising colorectal screening volumes, and procedural migration toward ambulatory surgical centers, single-use endoscopes and sterile consumable accessories are permanently replacing reusable endoscopy infrastructure.
Read Report Details
The U.S. single-use gastroenterology devices market is expanding rapidly, projected to grow from USD 3.18 billion in 2026 to USD 8.12 billion by 2032 at a 16.89% CAGR. Growth is driven by stringent infection control mandates, CMS reimbursement incentives, and procedural migration to ambulatory surgery centers, eliminating scope reprocessing bottlenecks and patient cross-contamination risks nationwide.
Read Report Details
The U.S. AI-enabled gastroenterology devices market is projected to grow from $2.52 billion in 2026 to $6.48 billion by 2032 at a 17.05% CAGR. Accelerated by guideline revisions lowering colorectal screening ages to 45 and expanding outpatient ASC volumes, real-time computer-aided detection and optical biopsy platforms systematically elevate adenoma detection rates and eliminate interval cancers nationwide.
Read Report Details
The U.S. Smart Gastroenterology Devices Market is projected to expand from USD 3.54 billion in 2026 to USD 7.22 billion by 2032, registering a 12.60% CAGR. Growth is driven by lowering the colorectal screening age to 45, rapid procedural migration to ambulatory surgery centers, widespread clinical adoption of edge-AI computer vision for lesion detection, and infection-control mandates favoring single-use duodenoscope designs.
Read Report Details
The U.S. Advanced Gastroenterology Devices Market is projected to grow from USD 6.20 billion in 2026 to USD 10.45 billion by 2032, advancing at a 9.10% CAGR. Growth is accelerated by earlier colorectal screening guidelines, the rapid expansion of ambulatory surgery centers, increasing volumes of interventional endotherapy, and standard-of-care migrations toward infection-controlled and single-use endoscopes.
Read Report Details
The U.S. Minimally Invasive Gastroenterology Devices Market is projected to expand from USD 10.62 billion in 2026 to USD 16.92 billion by 2032, advancing at an 8.07% CAGR. Growth is driven by the lowering of colorectal cancer screening guidelines to age 45, rapid procedure migration to ambulatory surgery centers, widespread clinical adoption of single-use endoscopes, and AI-assisted lesion detection platforms.
Read Report Details
The U.S. Gastrointestinal Endoscopy Devices Market is projected to grow from USD 7.42 billion in 2026 to USD 12.38 billion by 2032, expanding at an 8.91% CAGR. Market growth is propelled by lowering the colorectal screening age to 45, widespread migration toward ambulatory surgery centers, adoption of artificial intelligence diagnostic modules, and transitioning to single-use scopes to eliminate cross-contamination.
Read Report Details